Rheumatoid Arthritis Diagnostic Tests Market Share

Statistics for the 2023 & 2024 Rheumatoid Arthritis Diagnostic Tests market share, created by Mordor Intelligence™ Industry Reports. Rheumatoid Arthritis Diagnostic Tests share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Rheumatoid Arthritis Diagnostic Tests Industry

The rheumatoid arthritis diagnosis tests market is moderately competitive in nature due to the presence of several companies operating globally as well as regionally. Some market players are Abbott Laboratories, Augurex Life Sciences Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), Tulip Diagnostics (P) Ltd, Boditech Med Inc., and Bio-Rad Laboratories, Inc.

Rheumatoid Arthritis Diagnostic Tests Market Leaders

  1. Abbott Laboratories

  2. Siemens Healthineers AG

  3. Thermo Fisher Scientific Inc.

  4. Augurex Life Sciences Corp.

  5. Danaher Corporation (Beckman Coulter)

*Disclaimer: Major Players sorted in no particular order

Rheumatoid Arthritis Diagnostic Tests Market Concentration

Rheumatoid Arthritis Diagnostic Tests Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)